Highlights
- •SARS-CoV-2 viral loads peak from upper respiratory tract samples around symptom onset.
- •Viral loads from sputum samples may be higher than upper respiratory tract samples.
- •Viral loads appear to be similar between asymptomatic and symptomatic patients.
- •The prolonged virus detection in stool samples has unclear clinical significance.
- •Patients may not be infectious for the entire duration of virus detection.
Summary
Objectives
Methods
Results
Conclusion
Keywords
Introduction
HIQA publishes COVID-19 evidence summaries to support work of the National Public Health Emergency Team [press release]. https://www.hiqa.ie/hiqa-news-updates/hiqa-publishes-covid-19-evidence-summaries-support-work-national-public-health: HIQA, 1 April 2020.
- 1.What is the detection pattern and viral load of SARS-CoV-2 over the course of an infection (including any asymptomatic or pre-symptomatic phase)? Patients who remain symptomless throughout the duration of disease are referred to as ‘asymptomatic’, and those who are in the early stages of disease, after transmission has occurred, but in whom symptoms have not yet developed are referred to as ‘pre-symptomatic’.8
Health Information and Quality Authority. Protocol for evidence synthesis support - COVID-19. https://www.hiqa.ie/sites/default/files/2020-04/Protocol-for-evidence-synthesis-support_1-4-COVID-19.pdf: HIQA, 2020.
- 2.What is the duration of infectivity of SARS-CoV-2? Duration of infectivity is defined as the time interval during which an infectious agent may be transferred from an infected person to another person.8
Health Information and Quality Authority. Protocol for evidence synthesis support - COVID-19. https://www.hiqa.ie/sites/default/files/2020-04/Protocol-for-evidence-synthesis-support_1-4-COVID-19.pdf: HIQA, 2020.
Materials and methods
Health Information and Quality Authority. Protocol for evidence synthesis support - COVID-19. https://www.hiqa.ie/sites/default/files/2020-04/Protocol-for-evidence-synthesis-support_1-4-COVID-19.pdf: HIQA, 2020.
Health Information and Quality Authority. Protocol for evidence synthesis support - COVID-19. https://www.hiqa.ie/sites/default/files/2020-04/Protocol-for-evidence-synthesis-support_1-4-COVID-19.pdf: HIQA, 2020.
Health Information and Quality Authority. Protocol for evidence synthesis support - COVID-19. https://www.hiqa.ie/sites/default/files/2020-04/Protocol-for-evidence-synthesis-support_1-4-COVID-19.pdf: HIQA, 2020.
Population | Patients (of any age) infected with COVID-19 with information on either viral load or detection during infection (including in the pre-symptomatic phase) and/or duration of infectivity.
|
Outcomes | Primary outcomes:
|
Types of Studies | Include:
|
Results
Summary of included studies
- Fu S.
- Fu X.
- Song Y.
- Li M.
- P-h Pan
- Tang T.
- et al.
- Huang J.
- Mao T.
- Li S.
- Wu L.
- Xu X.
- Li H.
- et al.
- Jing Q.-.L.
- Liu M.-.J.
- Yuan J.
- Zhang Z.-.B.
- Zhang A.-R.
- Dean N.
- et al.
Jones T.C., Mühlemann B., Veith T., Zuchowski M., Hofmann J., Stein A., et al. An analysis of SARS-CoV-2 viral load by patient age. https://zoonosen.charite.de/fileadmin/user_upload/microsites/m_cc05/virologie-ccm/dateien_upload/Weitere_Dateien/analysis-of-SARS-CoV-2-viral-load-by-patient-age.pdf: 2020.
- Lavezzo E.
- Franchin E.
- Ciavarella C.
- Cuomo-Dannenburg G.
- Barzon L.
- Del Vecchio C.
- et al.
- L'Huillier A.
- Torriani G.
- Pigny F.
- Kaiser L.
- Eckerle I
- Yang P.
- Ding Y.
- Xu Z.
- Pu R.
- Li P.
- Yan J.
- et al.
- Yuan J.
- Kou S.
- Liang Y.
- Zeng J.
- Pan Y.
- Liu L
- Zhang N.
- Gong Y.
- Meng F.
- Bi Y.
- Yang P.
- Wang F
- Fu S.
- Fu X.
- Song Y.
- Li M.
- P-h Pan
- Tang T.
- et al.
- Jing Q.-.L.
- Liu M.-.J.
- Yuan J.
- Zhang Z.-.B.
- Zhang A.-R.
- Dean N.
- et al.
- Yang P.
- Ding Y.
- Xu Z.
- Pu R.
- Li P.
- Yan J.
- et al.
- Yuan J.
- Kou S.
- Liang Y.
- Zeng J.
- Pan Y.
- Liu L
- Zhang N.
- Gong Y.
- Meng F.
- Bi Y.
- Yang P.
- Wang F
- Lavezzo E.
- Franchin E.
- Ciavarella C.
- Cuomo-Dannenburg G.
- Barzon L.
- Del Vecchio C.
- et al.
Jones T.C., Mühlemann B., Veith T., Zuchowski M., Hofmann J., Stein A., et al. An analysis of SARS-CoV-2 viral load by patient age. https://zoonosen.charite.de/fileadmin/user_upload/microsites/m_cc05/virologie-ccm/dateien_upload/Weitere_Dateien/analysis-of-SARS-CoV-2-viral-load-by-patient-age.pdf: 2020.
- L'Huillier A.
- Torriani G.
- Pigny F.
- Kaiser L.
- Eckerle I
- Fu S.
- Fu X.
- Song Y.
- Li M.
- P-h Pan
- Tang T.
- et al.
- Huang J.
- Mao T.
- Li S.
- Wu L.
- Xu X.
- Li H.
- et al.
- Jing Q.-.L.
- Liu M.-.J.
- Yuan J.
- Zhang Z.-.B.
- Zhang A.-R.
- Dean N.
- et al.
Jones T.C., Mühlemann B., Veith T., Zuchowski M., Hofmann J., Stein A., et al. An analysis of SARS-CoV-2 viral load by patient age. https://zoonosen.charite.de/fileadmin/user_upload/microsites/m_cc05/virologie-ccm/dateien_upload/Weitere_Dateien/analysis-of-SARS-CoV-2-viral-load-by-patient-age.pdf: 2020.
- Lavezzo E.
- Franchin E.
- Ciavarella C.
- Cuomo-Dannenburg G.
- Barzon L.
- Del Vecchio C.
- et al.
- L'Huillier A.
- Torriani G.
- Pigny F.
- Kaiser L.
- Eckerle I
- Yang P.
- Ding Y.
- Xu Z.
- Pu R.
- Li P.
- Yan J.
- et al.
- Yuan J.
- Kou S.
- Liang Y.
- Zeng J.
- Pan Y.
- Liu L
- Zhang N.
- Gong Y.
- Meng F.
- Bi Y.
- Yang P.
- Wang F
- Fu S.
- Fu X.
- Song Y.
- Li M.
- P-h Pan
- Tang T.
- et al.
- Huang J.
- Mao T.
- Li S.
- Wu L.
- Xu X.
- Li H.
- et al.
- L'Huillier A.
- Torriani G.
- Pigny F.
- Kaiser L.
- Eckerle I